glp-1 receptor agonist creatine interaction Dietary supplement considerations during glucagon-like Peptide-1 treatment: A narrative review Signaling Pathways of the GLP-1

While these trials were not specifically designed to assess joint pain, patients with obesity-related joint pain who achieve significant weight loss through GLP-1 therapy often report improved mobility, reduced need for analgesics, and enhanced ability to engage in physical activitycreating a positive cycle of further weight management and joint health

Merrifield RB, Mojsov S

doi: 10.1016/J.SURVOPHTHAL.2023.07.002 86 SharmaAParachuriNKumarNSabooBTripathiHNKuppermannBDet al

I'm under a lot of stress because my company's downsizing

A pooled analysis of exenatide use and risk of acute pancreatitis

Patients who reinitiated therapy after discontinuation were censored